The NCI-K, represented by the CEO, Dr. Elias Melly, participated in the 16th KEMRI Annual Scientific & Health (KASH) Conference, convened under the theme: “Advancing Kenya’s Vaccine Research, Development and Manufacturing Capacity for Sustainable Health Security.”
The conference, which brought together leading scientists, policymakers, and global health experts, deliberated on strengthening Kenya’s vaccine ecosystem. Key sessions included a high-level roundtable on success factors in local vaccine manufacturing — spanning research and development, manufacturing capacity, technology transfer and intellectual property, skills development, regulatory pathways, quality standards, access to finance, supply chain systems, and market shaping. Discussions also explored Africa’s Initiative for Local Vaccine Manufacturing and advancing global vaccine end-to-end capabilities.
The Keynote Address was delivered by Prof. Shaukat Abdulrazak, PhD, EBS, Principal Secretary, State Department of Science, Research and Innovation, Ministry of Health, titled: “Kenya’s Vision and Journey in Local Vaccine Manufacturing.” The Chief Guest, Hon. Dr. Aden Duale, Cabinet Secretary for Health, graced the conference.
During the conference, Dr. Melly presented on breast cancer incidence trends in Kenya and the role of exposure data in strengthening cancer surveillance, highlighting the importance of leveraging data and research to inform prevention strategies and enhance national cancer control efforts.The forum reaffirmed the central role of research, innovation, and strategic partnerships in advancing health security and improving population health outcomes.
Leave a Reply